{"id":"https://openalex.org/W2014008583","doi":"https://doi.org/10.1021/jm950548u","title":"Antitumor Agents. 164. Podophenazine, 2\u2018\u2018,3\u2018\u2018-Dichloropodophenazine, Benzopodophenazine, and Their 4\u03b2-p-Nitroaniline Derivatives as Novel DNA Topoisomerase II Inhibitors","display_name":"Antitumor Agents. 164. Podophenazine, 2\u2018\u2018,3\u2018\u2018-Dichloropodophenazine, Benzopodophenazine, and Their 4\u03b2-p-Nitroaniline Derivatives as Novel DNA Topoisomerase II Inhibitors","alternate_titles":[],"publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W2014008583","doi":"https://doi.org/10.1021/jm950548u","mag":"2014008583","pmid":"https://pubmed.ncbi.nlm.nih.gov/8691469"},"language":"en","primary_location":{"id":"doi:10.1021/jm950548u","doi":"https://doi.org/10.1021/jm950548u","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm950548u","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2014008583"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076396692","display_name":"Sung Jin Cho","orcid":"https://orcid.org/0000-0002-4786-8830","observed_orcids":["https://orcid.org/0000-0002-4786-8830"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sung Jin Cho","raw_affiliation_strings":["Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, and Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, and Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075755992","display_name":"Yoshiki Kashiwada","orcid":"https://orcid.org/0000-0002-5429-3211","observed_orcids":["https://orcid.org/0000-0002-5429-3211"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoshiki Kashiwada","raw_affiliation_strings":["Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, and Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, and Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110322271","display_name":"Kenneth F. Bastow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth F. Bastow","raw_affiliation_strings":["Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, and Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, and Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112574222","display_name":"Yung-Chi Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yung-Chi Cheng","raw_affiliation_strings":["Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, and Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, and Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005512198","display_name":"Kuo\u2010Hsiung Lee","orcid":"https://orcid.org/0000-0002-6562-0070","observed_orcids":["https://orcid.org/0000-0002-6562-0070"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kuo-Hsiung Lee","raw_affiliation_strings":["Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, and Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, and Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.8993,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.86177406,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"39","issue":"7","first_page":"1396","last_page":"1402"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9506999850273132,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9506999850273132,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12360","display_name":"Plant-derived Lignans Synthesis and Bioactivity","score":0.03449999913573265,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibitors","display_name":"topoisomerase II inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/kb-cells","display_name":"KB cells","score":0.6620000004768372},{"id":"https://openalex.org/keywords/etoposide-resistance","display_name":"etoposide resistance","score":0.8169999718666077},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.7250000238418579},{"id":"https://openalex.org/keywords/differential-toxicity","display_name":"differential toxicity","score":0.4189999997615814}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9437059164047241},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.8098441362380981},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.5395914316177368},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5128719806671143},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4694608747959137},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3817756175994873},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2948417663574219},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004247","descriptor_name":"DNA","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004591","descriptor_name":"Electrophoresis, Polyacrylamide Gel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007624","descriptor_name":"KB Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010619","descriptor_name":"Phenazines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010619","descriptor_name":"Phenazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011034","descriptor_name":"Podophyllotoxin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D011034","descriptor_name":"Podophyllotoxin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm950548u","doi":"https://doi.org/10.1021/jm950548u","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm950548u","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:8691469","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8691469","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W338601501","https://openalex.org/W1552353351","https://openalex.org/W1589814349","https://openalex.org/W1986621896","https://openalex.org/W1994810131","https://openalex.org/W2012232448","https://openalex.org/W2015000379","https://openalex.org/W2021005712","https://openalex.org/W2052261000","https://openalex.org/W2058911936","https://openalex.org/W2068474888","https://openalex.org/W2073533584","https://openalex.org/W2074651320","https://openalex.org/W2095399842"],"related_works":["https://openalex.org/W2049020138","https://openalex.org/W2065428450","https://openalex.org/W2085550344","https://openalex.org/W60902290","https://openalex.org/W2275702541","https://openalex.org/W2003542356","https://openalex.org/W2036792089","https://openalex.org/W2003936177","https://openalex.org/W2072034796","https://openalex.org/W2049036980"],"abstract_inverted_index":{"We":[0,244],"report":[1],"here":[2],"the":[3,85,130,215,219,227,248],"synthesis":[4],"and":[5,19,22,32,50,116,121,140,155,186,241,255],"biological":[6],"evaluation":[7],"of":[8,71,78,94,129,133,221,229,232,239,250,252,270,273],"novel":[9],"DNA":[10,148],"topoisomerase":[11,72,134],"II":[12,135],"inhibitors,":[13],"podophenazine":[14],"(8),":[15],"2'',3''":[16],"\"-dichloropodophenazine":[17],"(9),":[18],"benzopodophenazine":[20],"(10),":[21],"their":[23],"4beta-p-nitroaniline":[24],"derivatives":[25,262],"13-15.":[26],"Among":[27],"these,":[28],"4'-0-demethyl-4beta-(4'''-":[29],"nitroanilino)-4-desoxypodophenazine":[30],"(13)":[31],"4'-O-demethyl-2'',3''-dichloro-4beta-(4-'''-nitroanilino)-4-":[33],"desoxypodophenazine":[34],"(14)":[35],"were":[36,123],"found":[37,124],"to":[38,125,214,265],"inhibit":[39],"KB":[40],"cells":[41,58],"at":[42,162,170,178,190,198,206],"sub-micromolar":[43,86],"concentrations":[44],"(IC50":[45],"=":[46,137],"0.11":[47],"+/-":[48,52,96,166,174,183,194,202,210],"0.03":[49],"0.48":[51],"0.17":[53],"microM,":[54,143,164,172,192,200,208],"respectively.":[55],"Against":[56],"KB/7d":[57],"(a":[59],"pleiotrophic":[60],"multiple":[61],"drug-resistant":[62],"subclone":[63],"selected":[64],"with":[65,89],"etoposide":[66,115,240],"which":[67],"has":[68],"reduced":[69],"level":[70],"II),":[73],"only":[74],"compound":[75],"13":[76,105,120,154,169,177,254],"out":[77],"a":[79,90],"target":[80],"series":[81,272],"maintained":[82],"activity":[83,132],"in":[84,263],"concentration":[87],"range":[88],"IC":[91],"50":[92,107,109,171,199],"value":[93],"0.56":[95],"0.13":[97],"mu":[98,180],"M.":[99],"The":[100],"differential":[101],"toxicity":[102],"ratio":[103],"for":[104],"[IC":[106],"(KB/7d)/IC":[108],"(KB)]":[110],"was":[111],"approximately":[112],"5.":[113],"Unlike":[114],"its":[117,242],"congeners,":[118],"compounds":[119,234,253],"14":[122,197,205,256],"be":[126],"weak":[127],"inhibitors":[128],"catalytic":[131],"(IC100":[136],">":[138,141],"100":[139,179,207],"150":[142],"respectively).":[144],"In":[145],"vitro":[146],"protein-linked":[147],"complex":[149],"formation":[150],"assay":[151],"revealed":[152],"that":[153,226,238],"14,":[156],"respectively,":[157],"induced":[158],"marginal":[159],"response":[160,188],"(13":[161],"1":[163,191],"320.3":[165],"124.5":[167],"cpm;":[168,176,196,204],"308.8":[173],"139.9":[175],"M,":[181],"446.0":[182],"153.5":[184],"cpm)":[185,212],"no":[187],"(14":[189],"104.9":[193],"52.6":[195],"103.3":[201],"42.6":[203],"101.4":[209],"35.2":[211],"compared":[213],"enzyme":[216,230],"control.":[217],"On":[218],"basis":[220],"these":[222,233],"results,":[223],"we":[224],"conclude":[225],"mechanism":[228],"inhibition":[231],"is":[235],"distinct":[236],"from":[237],"congeners.":[243],"are":[245],"currently":[246],"investigating":[247],"mechanism(s)":[249],"action":[251],"as":[257,259],"well":[258],"synthesizing":[260],"other":[261],"order":[264],"better":[266],"characterize":[267],"structure-activity":[268],"relationships":[269],"this":[271],"compounds.":[274]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2014008583","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
